Page last updated: 2024-10-28

hypericin and Leukemia, Promyelocytic, Acute

hypericin has been researched along with Leukemia, Promyelocytic, Acute in 2 studies

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research Excerpts

ExcerptRelevanceReference
"When treated with hypericin, the cell ratio reducible of nitroblue tetrazolium was significantly increased and the cell size was enlarged by flow cytometry analysis."1.30Hypericin induces both differentiation and apoptosis in human promyelocytic leukemia HL-60 cells. ( Chang, SG; Jung, JC; Kim, JI; Lee, KT; Miyamoto, K; Park, HJ; Park, JH; Rho, YS, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jarvis, WD1
Turner, AJ1
Povirk, LF1
Traylor, RS1
Grant, S1
Lee, KT1
Kim, JI1
Rho, YS1
Chang, SG1
Jung, JC1
Park, JH1
Park, HJ1
Miyamoto, K1

Other Studies

2 other studies available for hypericin and Leukemia, Promyelocytic, Acute

ArticleYear
Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
    Cancer research, 1994, Apr-01, Volume: 54, Issue:7

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Anthracenes; Antineoplastic Agents; Apopto

1994
Hypericin induces both differentiation and apoptosis in human promyelocytic leukemia HL-60 cells.
    Biological & pharmaceutical bulletin, 1999, Volume: 22, Issue:12

    Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Cell Differentiation; HL-60 Cells; Humans; Leukemia,

1999